Search

Author/Creator Ismail, Azza

1. Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. Issue 4 (December 2019)

Authors:
Ismail, Azza; Sharrack, Basil; Saccardi, Riccardo; Moore, John J.; Snowden, John A.
Journal:
Current opinion in supportive and palliative care
Issue:
Volume 13:Issue 4(2019:Dec.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

Authors:
Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu...
Journal:
Lancet neurology
Issue:
Volume 21:Issue 7(2022)
Page Start:
608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. Issue 1 (20th October 2012)

Authors:
Ismail, Azza; Cooper-Knock, Johnathan; Highley, J Robin; Milano, Antonio; Kirby, Janine; Goodall, Emily; Lowe, James; Scott, Ian; Constantinescu, Cris S; Walters, Stephen J; Price, Sian; McDermott, Christopher J; Sawcer, Stephen; Compston, D Alastair S; Sharrack, Basil; Shaw, Pamela J
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 84:Issue 1(2013)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolones. (1st January 2021)

Authors:
Elzahhar, Perihan A.; Alaaeddine, Rana A.; Nassra, Rasha; Ismail, Azza; Labib, Hala F.; Temraz, Mohamed G.; Belal, Ahmed S. F.; El-Yazbi, Ahmed F.
Journal:
Journal of enzyme inhibition and medicinal chemistry
Issue:
Volume 36:Number 1(2021)
Page Start:
669
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of remote ischaemic preconditioning on walking in people with multiple sclerosis: double-blind randomised controlled trial. Issue 1 (23rd March 2020)

Authors:
Chotiyarnwong, Chayaporn; Nair, Krishnan; Angelini, Lorenza; Buckley, Ellen; Mazza, Claudia; Heyes, Daniel; Ramiz, Ridha; Baster, Kathleen; Ismail, Azza; Das, Joyutpal; Ali, Ali; Lindert, Ralf; Sharrack, Basil; Price, Sian; Paling, David
Journal:
BMJ neurology open
Issue:
Volume 2:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus. (March 2023)

Authors:
Iyer, Priyanka; Wiles, Kate; Ismail, Azza; Nanda, Surabhi; Murray, Katy; Hughes, Stella; Ford, Helen L; Pearson, Owen R; White, Sarah; Bonham, Nicola; Hoyle, Natasha; Witts, James; Middleton, Rod; Brex, Peter A; Rog, David; Dobson, Ruth
Journal:
Multiple sclerosis
Issue:
Volume 29:Number 3(2023)
Page Start:
395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗